The battle against meningococcal disease, a potentially life-threatening bacterial infection, is gaining momentum with the increasing use of vaccines. The global Meningococcal Vaccines Market is experiencing a surge, driven by rising disease incidence worldwide. Currently valued at an estimated USD 3.95 billion in 2024, the market is projected to reach a staggering USD 9.014 billion …